Greenspring Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.85M Buy
7,578
+225
+3% +$52.4K 0.11% 90
2025
Q4
$1.52M Buy
+7,353
New +$1.45M 0.09% 96
2025
Q1
Sell
-1,548
Closed -$224K 101
2024
Q4
$224K Hold
1,548
0.05% 86
2024
Q3
$251K Hold
1,548
0.05% 77
2024
Q2
$226K Hold
1,548
0.05% 68
2024
Q1
$245K Hold
1,548
0.06% 65
2023
Q4
$243K Hold
1,548
0.07% 59
2023
Q3
$241K Hold
1,548
0.08% 49
2023
Q2
$256K Sell
1,548
-4,075
-72% -$658K 0.08% 51
2023
Q1
$872K Buy
5,623
+1,522
+37% +$246K 0.19% 53
2022
Q4
$724K Sell
4,101
-99
-2% -$17.1K 0.19% 55
2022
Q3
$686K Sell
4,200
-120
-3% -$20.3K 0.21% 52
2022
Q2
$768K Sell
4,320
-244
-5% -$43.5K 0.23% 46
2022
Q1
$809K Buy
4,564
+147
+3% +$25K 0.21% 40
2021
Q4
$756K Buy
+4,417
New +$723K 0.19% 41

Other funds holding JNJ

Greenspring Advisors's JNJ Position: Q1 2026 in Review

Greenspring Advisors increased its Johnson & Johnson (JNJ) stake by 3.1% in Q1 2026, buying an estimated $52.4K and bringing the position to 7,578 shares worth $1.85M. The position accounts for 0.11% of the portfolio, ranked #90.

Greenspring Advisors first reported a position in JNJ in Q4 2021 and has held it in 15 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Greenspring Advisors held 7,578 shares of Johnson & Johnson worth $1.85M as of Q1 2026.
  • Greenspring Advisors bought 225 Johnson & Johnson shares in Q1 2026, an estimated $52.4K.
  • Johnson & Johnson made up 0.11% of Greenspring Advisors's portfolio in Q1 2026, its #90 holding.
  • Greenspring Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 15 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Greenspring Advisors's 13F filing for Q1 2026, filed 5 May 2026.